Genetic alterations in both Janus Kinase 2 (Jak2) and thrombopoietin receptor myeloproliferative leukemic (MPL) virus oncogenes serve as molecular targets in the diagnosis of MPN [3]. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.